What's in BioDelivery Sciences International's pipeline?

BioDelivery Sciences International has 7 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 2 in Phase 1.

Which companies overlap with BioDelivery Sciences International's portfolio?

Top competitors by shared drug class: Mundipharma (China) Pharmaceutical Co. Ltd, University of California, San Francisco, Purdue Pharma LP, Ajay Wasan, MD, Msc, Asbjørn Mohr Drewes.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/biodelivery-sciences-international.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

BioDelivery Sciences International — Portfolio Competitive Intelligence Brief

BioDelivery Sciences International pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
BEMA™	BEMA™	phase 3	Buccal film delivery system		Pain Management / Multiple therapeutic areas
DFN-15 Active	DFN-15 Active	phase 3	Partial mu-opioid receptor agonist	Mu-opioid receptor (μ-OR)	Pain Management
EN3409	EN3409	phase 3	Partial mu-opioid receptor agonist	Mu-opioid receptor (μ-OR)	Pain Management / Opioid Use Disorder
BEMA Fentanyl	BEMA Fentanyl	phase 3	Opioid analgesic	Mu-opioid receptor (μ-OR)	Pain Management

Therapeutic area mix

Pain Management · 2
Pain · 1
Pain Management / Multiple therapeutic areas · 1
Pain Management / Opioid Use Disorder · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Mundipharma (China) Pharmaceutical Co. Ltd · 2 shared drug classes
University of California, San Francisco · 2 shared drug classes
Purdue Pharma LP · 2 shared drug classes
Ajay Wasan, MD, Msc · 1 shared drug class
Asbjørn Mohr Drewes · 1 shared drug class
Boston Children's Hospital · 1 shared drug class
Archimedes Development Ltd · 1 shared drug class
Brigham and Women's Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for BioDelivery Sciences International:

Cite this brief

Drug Landscape (2026). BioDelivery Sciences International — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biodelivery-sciences-international. Accessed 2026-05-14.